Nadia Jakobsen, Inge Larsen, Nicolai R Weber, Peter M H Heegaard, Ken S Pedersen
{"title":"Elevated levels of C-reactive protein and pig major acute phase protein in lame gestating sows.","authors":"Nadia Jakobsen, Inge Larsen, Nicolai R Weber, Peter M H Heegaard, Ken S Pedersen","doi":"10.3389/fvets.2025.1505132","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Lameness is a common clinical issue in gestating sows and a leading cause for early culling and antibiotic treatment. Diagnostic tools are limited, but acute acute phase proteins (APPs) could offer a fast and minimally invasive method for optimizing treatment. The aim of this study was to investigate whether APP level measurements can be used as a diagnostic tool, and to identify which major acute phase proteins are elevated in lame gestating sows.</p><p><strong>Methods: </strong>To determine this, blood samples were collected from the jugular vein of 50 lame and 50 clinically healthy gestating sows from 12 conventional herds. The samples were analyzed for C-reactive protein (CRP), haptoglobin, serum amyloid A, and pig major acute phase protein (Pig-MAP) levels using sandwich ELISA.</p><p><strong>Results: </strong>C-reactive protein and Pig-MAP were found to be significantly elevated in lame sows compared to clinically healthy sows (<i>p</i> < 0.05). The acute phase protein levels were 22.4 μg/ mL for CRP and 1.19 mg/mL for Pig-MAP in lame sows, compared to 14.7 μg/mL for CRP and 1.06 mg/mL for Pig-MAP in healthy sows.Acute phase protein levels were not associated with clinical signs of inflammation on the affected leg(s), and no differences were seen in hematology parameters between lame and healthy gestating sows.</p><p><strong>Conclusion: </strong>In this study, lameness was associated with an elevation in C-reactive protein and pig major acute phase protein.</p>","PeriodicalId":12772,"journal":{"name":"Frontiers in Veterinary Science","volume":"12 ","pages":"1505132"},"PeriodicalIF":2.6000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11880936/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Veterinary Science","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.3389/fvets.2025.1505132","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Lameness is a common clinical issue in gestating sows and a leading cause for early culling and antibiotic treatment. Diagnostic tools are limited, but acute acute phase proteins (APPs) could offer a fast and minimally invasive method for optimizing treatment. The aim of this study was to investigate whether APP level measurements can be used as a diagnostic tool, and to identify which major acute phase proteins are elevated in lame gestating sows.
Methods: To determine this, blood samples were collected from the jugular vein of 50 lame and 50 clinically healthy gestating sows from 12 conventional herds. The samples were analyzed for C-reactive protein (CRP), haptoglobin, serum amyloid A, and pig major acute phase protein (Pig-MAP) levels using sandwich ELISA.
Results: C-reactive protein and Pig-MAP were found to be significantly elevated in lame sows compared to clinically healthy sows (p < 0.05). The acute phase protein levels were 22.4 μg/ mL for CRP and 1.19 mg/mL for Pig-MAP in lame sows, compared to 14.7 μg/mL for CRP and 1.06 mg/mL for Pig-MAP in healthy sows.Acute phase protein levels were not associated with clinical signs of inflammation on the affected leg(s), and no differences were seen in hematology parameters between lame and healthy gestating sows.
Conclusion: In this study, lameness was associated with an elevation in C-reactive protein and pig major acute phase protein.
期刊介绍:
Frontiers in Veterinary Science is a global, peer-reviewed, Open Access journal that bridges animal and human health, brings a comparative approach to medical and surgical challenges, and advances innovative biotechnology and therapy.
Veterinary research today is interdisciplinary, collaborative, and socially relevant, transforming how we understand and investigate animal health and disease. Fundamental research in emerging infectious diseases, predictive genomics, stem cell therapy, and translational modelling is grounded within the integrative social context of public and environmental health, wildlife conservation, novel biomarkers, societal well-being, and cutting-edge clinical practice and specialization. Frontiers in Veterinary Science brings a 21st-century approach—networked, collaborative, and Open Access—to communicate this progress and innovation to both the specialist and to the wider audience of readers in the field.
Frontiers in Veterinary Science publishes articles on outstanding discoveries across a wide spectrum of translational, foundational, and clinical research. The journal''s mission is to bring all relevant veterinary sciences together on a single platform with the goal of improving animal and human health.